Travoprost in the treatment of glaucoma

被引：2

作者：

Bazzaz, Sheila ^{[1
]}

Myers, Jonathan S. ^{[1
]}

Katz, L. Jay ^{[1
]}

机构：

[1] Wills Eye Inst, Dept Glaucoma, 840 Walnut St,Suite 1150, Philadelphia, PA 19107 USA

来源：

EXPERT REVIEW OF OPHTHALMOLOGY | 2007年 / 2卷 / 02期

关键词：

glaucoma; hypotensive lipids; intraocular pressure; ocular hypertension; optic neuropathy; prostaglandin analogs; travoprost;

D O I：

10.1586/17469899.2.2.177

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Glaucoma is one of the leading causes of irreversible blindness worldwide. Currently, intraocular pressure is the only modifiable risk factor for glaucoma and therapies aimed at reducing the intraocular pressure are the only known methods to reduce the progression of optic neuropathy. Prostaglandin analogs, including travoprost, have been shown to be the most effective drug class in reducing intraocular pressure. This article will highlight the role of travoprost in the management of glaucoma with regards to its efficacy and side effects, and in relation to those of alternative prostaglandins.

引用

页码：177 / 183

页数：7

共 51 条

[1] A study of iridectomy histopathologic features of latanoprost- and non-latanoprost-treated patients [J].

Albert, DM ;

Gangnon, RE ;

Zimbric, ML ;

Damico, CM ;

Fisher, MR ;

Gleiser, J ;

Grossniklaus, HE ;

Green, WR .

ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (11) :1680-1685

[2] Prostaglandin analog treatment of glaucoma and ocular hypertension [J].

Alexander, CL ;

Miller, SJ ;

Abel, SR .

ANNALS OF PHARMACOTHERAPY, 2002, 36 (03) :504-511

[3] Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia - A 6-month randomized trial [J].

Arcieri, ES ;

Santana, A ;

Rocha, FN ;

Guapo, GL ;

Costa, VP .

ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (02) :186-192

[4] Accuracy of an electronic monitoring and reminder device for use with travoprost eye drops [J].

Boden, C ;

Sit, A ;

Weinreb, RN .

JOURNAL OF GLAUCOMA, 2006, 15 (01) :30-34

[5] Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgery [J].

Camras, CB ;

Toris, CB ;

Sjoquist, B ;

Milleson, M ;

Thorngren, JO ;

Hejkal, TW ;

Patel, N ;

Barnett, EM ;

Smolyak, R ;

Hasan, F ;

Hellman, C ;

Meza, JL ;

Wax, MB ;

Stjernschantz, J .

OPHTHALMOLOGY, 2004, 111 (12) :2193-2198

[6]

CHEW PTK, 2006, ASIAN J OPHTHALMOL, V8, P13

[7]

Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477

[8] Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated Intraocular pressure [J].

Dubiner, HB ;

Sircy, MD ;

Landry, T ;

Bergamini, MV ;

Silver, LH ;

Turner, FD ;

Robertson, S ;

Andrew, RM ;

Weiner, A ;

Przydryga, J .

CLINICAL THERAPEUTICS, 2004, 26 (01) :84-91

[9] Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice [J].

Farmer, KC .

CLINICAL THERAPEUTICS, 1999, 21 (06) :1074-1090

[10]

Farris EP, AM AC OPHTH

← 1 2 3 4 5 6 →